Top

Published in:

01-09-2015 | Original Contribution

Behavior in children with Prader–Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study

Authors: Sin T. Lo, Elbrich P. C. Siemensma, Dederieke A. M. Festen, Philippe J. L. Collin, Anita C. S. Hokken-Koelega

Published in: European Child & Adolescent Psychiatry | Issue 9/2015

Abstract

Information on behavior of children with Prader–Willi syndrome (PWS) and the effect of growth hormone (GH) treatment is scarce. Parents report less problem behavior during GH treatment. Forty-two pre-pubertal children, aged 3.5–14 years were studied in a randomized controlled GH trial (RCT) during 2 years, followed by a longitudinal study during 8 years of GH treatment. Behavior was measured annually by the Developmental Behavior Checklist for children with intellectual disability (DBC) and a Dutch questionnaire to evaluate social behavioral problems in children, the Children’s Social Behavior Questionnaire (CSBQ). Problem behavior measured by the DBC in children with PWS was similar compared to peers with comparable intellectual disability. Scores on ‘Social disabilities’ subscale were however significantly higher compared to the DBC total score (p < 0.01). A lower IQ was associated with more self-absorbed behavior, more communication problems and more problem behavior in general. Problem behavior measured by the CSBQ was similar compared to peers with a comparable intellectual disability, but children with PWS scored significantly higher on the ‘Not tuned’, ‘Understanding’, and ‘Stereotyped’ subscales than the CSBQ total score (p < 0.05 for all subscales and p = 0.001 for the ‘Not tuned’-subscale). There were no significant effects of GH treatment during the RCT and 8 years of GH treatment. Children with PWS showed similar problem behavior as a reference population with a comparable intellectual disability. Social problems were the most pronounced within-problem behavior in PWS. In contrast to our expectations and parents reports, our study shows no improvement but also no deterioration of behavioral problems in children with PWS during long-term GH treatment.

Available only for authorised users

Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader–Willi syndrome. Genet Med 14(1):10–26. doi:10.1038/gim.0b013e31822bead0 PubMedCrossRef

Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F (1993) Prader–Willi syndrome: consensus diagnostic criteria. Pediatrics 91(2):398–402PubMed

Descheemaeker MJ, Vogels A, Govers V, Borghgraef M, Willekens D, Swillen A, Verhoeven W, Fryns JP (2002) Prader–Willi syndrome: new insights in the behavioural and psychiatric spectrum. J Intellect Disabil Res 46(Pt 1):41–50. doi:10.1046/j.1365-2788.2002.00354 PubMedCrossRef

Curfs LM, Hoondert V, van Lieshout CF, Fryns JP (1995) Personality profiles of youngsters with Prader–Willi syndrome and youngsters attending regular schools. J Intellect Disabil Res 39(Pt 3):241–248PubMedCrossRef

Curfs LM, Verhulst FC, Fryns JP (1991) Behavioral and emotional problems in youngsters with Prader–Willi syndrome. Genet Couns 2(1):33–41PubMed

Dykens EM, Cassidy SB (1995) Correlates of maladaptive behavior in children and adults with Prader–Willi syndrome. Am J Med Genet 60(6):546–549PubMedCrossRef

Dykens EM, Hodapp RM, Walsh K, Nash LJ (1992) Adaptive and maladaptive behavior in Prader–Willi syndrome. J Am Acad Child Adolesc Psychiatry 31(6):1131–1136PubMedCrossRef

Dykens EM, Kasari C (1997) Maladaptive behavior in children with Prader–Willi syndrome, Down syndrome, and nonspecific mental retardation. Am J Ment Retard 102(3):228–237PubMedCrossRef

Dykens EM, Leckman JF, Cassidy SB (1996) Obsessions and compulsions in Prader–Willi syndrome. J Child Psychol Psychiatry 37(8):995–1002PubMedCrossRef

10.

Einfeld SL, Smith A, Durvasula S, Florio T, Tonge BJ (1999) Behavior and emotional disturbance in Prader–Willi syndrome. Am J Med Genet 82(2):123–127. doi:10.1002/(SICI)1096-8628(19990115)82:2<123:AID-AJMG4>3.0.CO;2-C PubMedCrossRef

11.

Stein DJ, Keating J, Zar HJ, Hollander E (1994) A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader–Willi syndrome. J Neuropsychiatr Clin Neurosci 6(1):23–29CrossRef

12.

Akefeldt A, Gillberg C (1999) Behavior and personality characteristics of children and young adults with Prader–Willi syndrome: a controlled study. J Am Acad Child Adolesc Psychiatr 38(6):761–769CrossRef

13.

Dykens EM, Rosner BA (1999) Refining behavioral phenotypes: personality-motivation in Williams and Prader–Willi syndromes. Am J Ment Retard 104(2):158–169. doi:10.1352/0895-8017(1999)104<0158:RBPPIW>2.0.CO;2 PubMedCrossRef

14.

Lo ST, Siemensma E, Collin P, Hokken-Koelega A (2013) Impaired theory of mind and symptoms of Autism Spectrum Disorder in children with Prader–Willi syndrome. Res Dev Disabil 34(9):2764–2773. doi:10.1016/j.ridd.2013.05.024 PubMedCrossRef

15.

Bakker NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Bindels-de Heus GC, Bocca G, Haring DA, Hoorweg-Nijman JJ, Houdijk EC, Jira PE, Lunshof L, Odink RJ, Oostdijk W, Rotteveel J, Schroor EJ, Van Alfen AA, Van Leeuwen M, Van Pinxteren-Nagler E, Van Wieringen H, Vreuls RC, Zwaveling-Soonawala N, de Ridder MA, Hokken-Koelega AC (2013) Eight Years of Growth Hormone Treatment in Children With Prader–Willi Syndrome: maintaining the Positive Effects. J Clin Endocrinol Metab 98(10):4013–4022. doi:10.1210/jc.2013-2012 PubMedCrossRef

16.

Haqq AM, Stadler DD, Jackson RH, Rosenfeld RG, Purnell JQ, LaFranchi SH (2003) Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader–Willi syndrome. J Clin Endocrinol Metab 88(5):2206–2212PubMedCrossRef

17.

Whitman BY, Myers S, Carrel A, Allen D (2002) The behavioral impact of growth hormone treatment for children and adolescents with Prader–Willi syndrome: a 2-year, controlled study. Pediatrics 109(2):E35PubMedCrossRef

18.

Dekker MC, Nunn RJ, Einfeld SE, Tonge BJ, Koot HM (2002) Assessing emotional and behavioral problems in children with intellectual disability: revisiting the factor structure of the developmental behavior checklist. J Autism Dev Disord 32(6):601–610PubMedCrossRef

19.

Hartman CA, Luteijn E, Serra M, Minderaa R (2006) Refinement of the Children’s Social Behavior Questionnaire (CSBQ): an instrument that describes the diverse problems seen in milder forms of PDD. J Autism Dev Disord 36(3):325–342. doi:10.1007/s10803-005-0072-z19 PubMedCrossRef

20.

Descheemaeker MJ, Govers V, Vermeulen P, Fryns JP (2006) Pervasive developmental disorders in Prader–Willi syndrome: the Leuven experience in 59 subjects and controls. Am J Med Genet Part A 140(11):1136–1142. doi:10.1002/ajmg.a.31235 PubMedCrossRef

21.

Dimitropoulos A, Ho A, Feldman B (2012) Social responsiveness and competence in Prader–Willi syndrome: direct comparison to autism spectrum disorder. J Autism Dev Disord. doi:10.1007/s10803-012-1547-3

22.

Dykens EM (2004) Maladaptive and compulsive behavior in Prader–Willi syndrome: new insights from older adults. Am J Ment Retard 109(2):142–153. doi:10.1352/0895-8017(2004)109<142:MACBIP>2.0.CO;2 PubMedCrossRef

23.

Veltman MW, Thompson RJ, Roberts SE, Thomas NS, Whittington J, Bolton PF (2004) Prader–Willi syndrome–a study comparing deletion and uniparental disomy cases with reference to autism spectrum disorders. Eur Child Adolesc Psychiatry 13(1):42–50. doi:10.1007/s00787-004-0354-6 PubMedCrossRef

24.

Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, Roede MJ, Verloove-Vanhorick SP, Wit JM (2000) Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res 47(3):316–323PubMedCrossRef

25.

Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP (2000) Body index measurements in 1996-7 compared with 1980. Arch Dis Child 82(2):107–112PubMedCentralPubMedCrossRef

26.

Siemensma EP, Tummers-de Lind van Wijngaarden RF, Festen DA, Troeman ZC, van Alfen-van der Velden AA, Otten BJ, Rotteveel J, Odink RJ, Bindels-de Heus GC, van Leeuwen M, Haring DA, Oostdijk W, Bocca G, Mieke Houdijk EC, van Trotsenburg AS, Hoorweg-Nijman JJ, van Wieringen H, Jira PE, Schroor EJ, van Pinxteren-Nagler E, Pilon JW, Lunshof LB, Hokken-Koelega AC (2012) Beneficial Effects of Growth Hormone Treatment on Cognition in Children with Prader–Willi Syndrome: a Randomized Controlled Trial and Longitudinal Study. J Clin Endocrinol Metab 97(7):2307–2314. doi:10.1210/jc.2012-1182 PubMedCrossRef

27.

West BT (2009) Analyzing longitudinal data with the linear mixed models procedure in SPSS. Eval Health Prof 32(3):207–228. doi:10.1177/0163278709338554 PubMedCrossRef

28.

van Pareren YK, Duivenvoorden HJ, Slijper FS, Koot HM, Hokken-Koelega AC (2004) Intelligence and psychosocial functioning during long-term growth hormone therapy in children born small for gestational age. J Clinical Endocrinol Metab 89(11):5295–5302. doi:10.1210/jc.2003-031187 CrossRef

29.

van der Reijden-Lakeman IE, de Sonneville LM, Swaab-Barneveld HJ, Slijper FM, Verhulst FC (1997) Evaluation of attention before and after 2 years of growth hormone treatment in intrauterine growth retarded children. J Clin Exp Neuropsychol 19(1):101–118. doi:10.1080/01688639708403840 PubMedCrossRef

30.

Festen DA, Wevers M, Lindgren AC, Bohm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC (2008) Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader–Willi syndrome. Clin Endocrinol (Oxf) 68(6):919–925. doi:10.1111/j.1365-2265.2007.03126.x CrossRef

31.

Reus L, Pelzer BJ, Otten BJ, Siemensma EP, van Alfen-van der Velden JA, Festen DA, Hokken-Koelega AC, Nijhuis-van der Sanden MW, Hokken-Koelega AC (2013) Growth hormone combined with child-specific motor training improves motor development in infants with Prader–Willi syndrome: a randomized controlled trial. Res Dev Disabil 34(10):3092–3103. doi:10.1016/j.ridd.2013.05.043 PubMedCrossRef

32.

Bohm B, Ritzen EM, Lindgren AC (2014) Growth hormone treatment improves vitality and behavioural issues in children with Prader–Willi syndrome. Acta Paediatr. doi:10.1111/apa.12813 PubMed

33.

Koenig K, Klin A, Schultz R (2004) Deficits in social attribution ability in Prader–Willi syndrome. J Autism Dev Disord 34(5):573–582. doi:10.1007/s10803-004-2551-2 PubMedCrossRef

34.

Clarke DJ, Boer H, Chung MC, Sturmey P, Webb T (1996) Maladaptive behaviour in Prader–Willi syndrome in adult life. J Intellect Disabil Res 40(Pt 2):159–165PubMedCrossRef

35.

van Lieshout CF, de Meyer RE, Curfs LM, Koot HM, Fryns JP (1998) Problem behaviors and personality of children and adolescents with Prader–Willi syndrome. J Pediatr Psychol 23(2):111–120PubMedCrossRef

36.

Milner KM, Craig EE, Thompson RJ, Veltman MW, Thomas NS, Roberts S, Bellamy M, Curran SR, Sporikou CM, Bolton PF (2005) Prader–Willi syndrome: intellectual abilities and behavioural features by genetic subtype. J Child Psychol Psychiatry 46(10):1089–1096. doi:10.1111/j.1469-7610.2005.01520.x PubMedCrossRef

37.

Dykens EM, Roof E (2008) Behavior in Prader–Willi syndrome: relationship to genetic subtypes and age. J Child Psychol Psychiatry 49(9):1001–1008. doi:10.1111/j.1469-7610.2008.01913.x PubMedCrossRef

38.

Whittington JE, Butler JV, Holland AJ (2007) Changing rates of genetic subtypes of Prader–Willi syndrome in the UK. Eur J Hum Genet 15(1):127–130. doi:10.1038/sj.ejhg.5201716 PubMedCrossRef

39.

Sinnema M, Boer H, Collin P, Maaskant MA, van Roozendaal KE, Schrander-Stumpel CT, Curfs LM (2011) Psychiatric illness in a cohort of adults with Prader–Willi syndrome. Res Dev Disabil 32(5):1729–1735. doi:10.1016/j.ridd.2011.02.027 PubMedCrossRef

Title: Behavior in children with Prader–Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study
Authors: Sin T. Lo
Elbrich P. C. Siemensma
Dederieke A. M. Festen
Philippe J. L. Collin
Anita C. S. Hokken-Koelega
Publication date: 01-09-2015
Publisher: Springer Berlin Heidelberg
Published in: European Child & Adolescent Psychiatry / Issue 9/2015
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-014-0662-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Behavior in children with Prader–Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2015

Where are the strongest associations between autistic traits and traits of ADHD? evidence from a community-based twin study

Ten-year trends in adolescents’ self-reported emotional and behavioral problems in the Netherlands

Lateral preference in Williams–Beuren syndrome is associated with cognition and language

Childhood neurodevelopmental problems and adolescent bully victimization: population-based, prospective twin study in Sweden

Quality of life in children with OCD before and after treatment

Sex-specific and time-dependent effects of prenatal stress on the early behavioral symptoms of ADHD: a longitudinal study in China